2011 Research Articles

By Cedars-Sinai Team/ Dr Pimentel:

• History of Tonsillectomy is Associated with IBS. - letter to the editor

• Effects of rifaximin treatment and retreatment in nonconstipated IBS subjects.

• Efficacy of the glucagon-like peptide-1 agonist exenatide in the treatment of short bowel syndrome.

• Acute and Chronic Histological Changes of the Small Bowel Secondary to C. jejuni Infection in a Rat Model for Post-Infectious IBS.

• Inflammation and microflora.

• Importance of Diarrhea in Evaluating Constipation in Irritable Bowel Syndrome Clinical Studies.

• Methane on breath testing is associated with constipation: a systematic review and meta-analysis.

• Relationships among the lactulose breath test, intestinal gas volume, and gastrointestinal symptoms in patients with irritable bowel syndrome.

• Antibiotic prophylaxis prevents the development of a post-infectious phenotype in a new rat model of post-infectious IBS.

• Rifaximin therapy for patients with irritable bowel syndrome without constipation.

• Factor analysis demonstrates a symptom cluster related to methane and non-methane production in irritable bowel syndrome.

By Dr Weinstock (& associates):

• Long-Term Outcome of Rifaximin Therapy in Non-constipation Irritable Bowel Syndrome.

• Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin.

• Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowth.

• Rosacea in Crohn's Disease: Effect of Rifaximin.

By Rome, Italy team:

• Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture.

• Prevalence of small intestinal bacterial overgrowth in Parkinson's disease.

Others:

• Oral antibiotic therapy improves fat absorption in cystic fibrosis patients with small intestine bacterial overgrowth.

• Gastrointestinal transit in patients with systemic sclerosis.
• Small intestinal bacterial overgrowth and Helicobacter pylori: can they be cause of thrombocytopenia in patients with chronic liver disease?

• When to reconsider the diagnosis of irritable bowel syndrome.

• Probable interaction between warfarin and rifaximin in a patient treated for small intestine bacterial overgrowth.

• Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery.

• Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome: frequency and predictors.

• Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective.

• Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture.

• The role of small intestinal bacterial overgrowth in postgastrectomy patients.

• Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure.
• Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS.
• Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.

In Spanish:

• [Comparative clinical efficacy of a probiotic vs. an antibiotic in the treatment of patients with intestinal bacterial overgrowth and chronic abdominal functional distension: a pilot study].

In Russian:

• [Rationale for the allocation of clinical variants of the postcholecystectomical syndrome associated with bacterial overgrowth in the small intestine].

• [Diagnosis and treatment of the bacterial overgrowth syndrome in the small intestine].
• [Enterosan--perspective medications for patients with postinfection irritable bowel syndrome].

• [Rifaximin application in the overgrowth bacterial syndrome in the small intestine in patients after cholecystectomy].

• [Treatment of disbacteriosis of gastroduodenal mucous microflora in mucosa inflammation, ulcer and erosion].

15% Off All Supplements at Fullscript

If you value this website, consider supporting the free information provided on siboinfo.com and it's newsletter, which helps SIBO sufferers world wide.

Site author:  Dr Allison Siebecker